Key Insights

Highlights

Treatment Research

2 treatments under study, led by Zovirax 50 Mgg Crema

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYF11dd4a5751c54300a4096f9797d78c98Phase 3Recruiting

Clinical trial to investigate the efficacy and tolerability of Lipovir® Gel (Acyclovir 5%) compared to Zovirax® Cream (Acyclovir 5%) and placebo on patients with recurrent herpes labialis

Showing all 1 trials

Research Network

Common Treatments

  • Zovirax 50 Mgg Crema1
  • Lipovir 50 Mgg Gel1

Active Sponsors

  • Laboratorios Ojer Pharma S.L.1

Activity Timeline